Skip to main content
SpringerLink
Log in

Dermatomyositis

  • Chapter
Pädiatrische Rheumatologie

  • 776 Accesses

Auszug

Die Dermatomyositis ist eine systemische entzündliche Bindegewebserkrankung unklarer Ätiologie, deren Hauptmanifestationen eine Entzündung der Muskulatur und charakteristische Hauterscheinungen sind. Die Pathogenese kann wahrscheinlich auf eine Vaskulopathie zurückgeführt werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Al-Maouf S, Al-Mazyed A, Bahabri S (2000) Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolon and methotrexate. Clin Rheumatol 19: 138–141

    Article  Google Scholar 

  • Al-Mayouf SM, Laxer RM, Schneider R et al. (2000) Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety. J Rheumatol 27: 2498–2503

    PubMed  CAS  Google Scholar 

  • Ambler GR, Chaitow J, Rogers M et al. (2005) Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy. J Rheumatol 32: 1837–1839

    PubMed  Google Scholar 

  • Ansell BM (1984) Management of polymyositis and dermatomyositis. Clin Rheum Dis 10: 205–213

    PubMed  CAS  Google Scholar 

  • Artlett CM, Ramos R, Jiminez SA et al. (2000) Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Childhood Myositis Heterogeneity Collaborative Group. Lancet 356: 2155–2156

    Article  PubMed  CAS  Google Scholar 

  • Bitnum S, Daeschner CWJ, Travis LB et al. (1964) Dermatomyositis. J Pediatr 64: 101–131

    Article  PubMed  CAS  Google Scholar 

  • Bloom BJ, Tucker L, Miller LC, Schaller JG (1995) Von Willebrand factor in juvenile dermatomyositis. J Rheumatol 22: 320–325

    PubMed  CAS  Google Scholar 

  • Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts) N Engl J Med 292: 344–402

    Article  PubMed  CAS  Google Scholar 

  • Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292: 403–407

    Article  PubMed  CAS  Google Scholar 

  • British Medical Research Council (1981) Aids to the examination of the peripheral nervous system; Memorandum no. 45. Her Majesty’s Stationery Office, London.

    Google Scholar 

  • Brown VE, Pilkington CA, Feldman BM et al. on behalf of the network for juvenile dermatomyositis, a working party of the Paediatric Rheumatology European Society (PreS) (2006) An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM). Rheumatology (Oxford)

    Google Scholar 

  • Cassidy JT et al. (eds) (2005) Textbook of pediatric rheumatology, 5th edn. Saunders, Philadelphia

    Google Scholar 

  • Cherin P, Herson S, Wechsler B et al. (1991) Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients. Am J Med 91: 162–168

    Article  PubMed  CAS  Google Scholar 

  • Christensen ML, Pachman LM, Schneiderman R et al. (1986) Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 29: 1365

    Article  PubMed  CAS  Google Scholar 

  • Crowne WE, Bove KE, Levinson JE et al. (1982) Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis. Arthritis Rheum 25: 126–139

    Article  Google Scholar 

  • Dalakas MC, Illa I, Dambrosia JM et al. (1994) A controlled trial of highdose intravenous immuneglobulin infusions as treatment for dermatomyositis. New Engl J med 330(19): 1392–1402

    Article  Google Scholar 

  • Dubowitz V. (1976) Treatment of dermatomyositis in childhood. Arch Dis Child 51: 494–500

    PubMed  CAS  Google Scholar 

  • Esiri MM, MacLennan IC, Hazleman BL (1973) Lymphocyte sensivity to skeletal muscle in patients with polymyositis and other disorders. Clin Exp Immunol 14: 25–35

    PubMed  CAS  Google Scholar 

  • Falcini F, Calzolari A, Generini S et al. (2000) Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. Clin Exp Rheumatol 18: 643–646

    PubMed  CAS  Google Scholar 

  • Feldman BM, Ayling-Campos A, Luy L et al. (1995) Measuring disability in juvenile dermatomyositis: validity of the childhood assessment questionnaire. J Rheumatol 22: 316–331

    Google Scholar 

  • Foeldvari I, Ruperto N, Dressler F et al. (2001) Paediatric Rheumatology International Trials Organisation. The German version of the childhood health assessment questionnaire (CHAQ) and the child health questionnaire (CHQ). Clin Exp Rheumatol 19(Suppl 23): S71–75

    PubMed  CAS  Google Scholar 

  • Fujikawa S, Okuni M (1997) A nationwide surveillance study of rheumatic diseases among Japanese children. Acta Paediatr Jpn 39: 242–244

    PubMed  CAS  Google Scholar 

  • Goncaleves FG, Chimelli I, Sallum AM et al. (2002) Immunohistological analysis of CD59 and membrane attack complex of complement in muscle in juvenile dermatomyositis. J Rheumatol 29: 1301–1307

    Google Scholar 

  • Guzman J, Petty RE, Malleson PN (1994) Monitoring disease activity in juvenile dermatomyositis: The role of von Willebrand factor and muscle enzymes. J Rheumatol 21: 739–743

    PubMed  CAS  Google Scholar 

  • Harati Y, Niakan E, Bergman EW (1986) Childhood dermatomyositis in monozygotic twins. Neurology 36: 721

    PubMed  CAS  Google Scholar 

  • Heckmatt J, Hasson N, Saunders C et al. (1989) Cyclosporine in juvenile dermatomyositis. Lancet 1: 1063–1066

    Article  PubMed  CAS  Google Scholar 

  • Hirsch TJ, Enlow RW, Bias WB et al. (1981) HLA-D related (DR) antigens in vanous kinds of myositis. Hum Immunol 3: 181–186

    Article  PubMed  CAS  Google Scholar 

  • Hoffman EP, Rao D, Pachman LM (2002) Clarifying the boundaries between the inflammatory and dystrophic myopathies insights from molecular diagnostics and microarrays. Rheum Dis Clin North Am 28: 743–757

    Article  PubMed  Google Scholar 

  • Huang JL (1996) Juvenile dermatomyositis associated with partial lipodystrohy. Br J Clin Pract 50: 112–113

    PubMed  CAS  Google Scholar 

  • Huang JL (1999) Long-term prognosis of patients with juvenile dermatomyositis initially treated with intravenous methylprednisolone pulse therapy. Clin Exp Rheumatol 17: 621–624

    PubMed  CAS  Google Scholar 

  • Huber AM, Lang B, LeBlanc CM et al. (2000) Medium-and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 43: 541–549

    Article  PubMed  CAS  Google Scholar 

  • Huemer C, Kitson H, Malleson PN et al. (2001) Lipodystrophy in patients with juvenile dermatomyositis-evaluation of clinical and metabolic abnormalities. J Rheumatol 28: 610–615

    PubMed  CAS  Google Scholar 

  • Huppertz HI (1999) Treatment of juvenile dermatomyositis with high-dose oral steroids or with steroid-pulse-therapy plus low dose oral steroids. Ann Rheum Dis 58(Suppl): 345

    Google Scholar 

  • Huppertz HI (2001) In: Wahn V, Oppermann J, Huppertz HI, Zepp F (Hrsg) Rheumatische Erkrankungen im Kindes-und Jugendalter. Hans Marseille, München

    Google Scholar 

  • Jacobs JC (1977) Methotrexate and azathioprine treatment of childhood dermatomyositis. Pediatrics 59: 212–218

    PubMed  CAS  Google Scholar 

  • Kaipiainen-Seppanen O, Savolainen A (1996) Incidence of chronic juvenile rheumatic diseases in Finland during 1980–1990. Clin Exp Rheumatol 14: 441–444

    PubMed  CAS  Google Scholar 

  • Kane D, Grassi W, Sturrock R, Balint PV (2004) Musculoskeletal ultrasound-a stat of the art review in rheumatology. Rheumatology (Oxford) 43: 829–838

    Article  PubMed  CAS  Google Scholar 

  • Kimball AB, Summers RM, Turner M et al. (2000) Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Arthritis Rheum 43: 1866–1873

    Article  PubMed  CAS  Google Scholar 

  • Lovell DJ, Lindsley CB, Rennenbohm RM et al. (1999) Development of validated disease avtivity and damage indices for the juvenile idiopathic inflammatory myopathies: II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 42: 2213–2219

    Article  PubMed  CAS  Google Scholar 

  • Maillard SM, Wilkinson N, Riley P et al. (2002) The treatment of persistent idiopathic inflammatory myositis with anti-TNFa therapy. Arthritis Rheum 46(Suppl): S307

    Google Scholar 

  • Mendez EP, Lipton R, Ramsey-Goldman R et al. (2003) US, incidence of juvenile dermatomyositis, 1995–1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 49: 300–305

    Article  PubMed  Google Scholar 

  • Miller ML, Smith RL, Abbott KA et al. (2002) Use of etanercept in chronic juvenile dermatomyositis (JDM). Arthritis Rheum 46(Suppl.): S306

    Google Scholar 

  • Montecucco C, Ravelli A, Caporali R et al. (1990) Autoantibodies in juvenile dermatomyositis. Clin Exp Rheumatol 8: 193–196

    PubMed  CAS  Google Scholar 

  • Pachman LM, Cooke N (1980) Juvenile dermatomyositis a clinical and immunologic study. J Pediatr 96: 226–234

    Article  PubMed  CAS  Google Scholar 

  • Pachman LM, Hayford JR, Hochberg MC et al. (1992) Seasonal onset in juvenile dermatomyositis (JDMS): an epidemiological study. Arthritis Rheum 35: 588

    Google Scholar 

  • Pachman LM, Callen AM, Hayford J et al. (1994) Juvenile dermatomyositis (JDMS): decreased calcinosis with intermittend high dose intravenous methylprednisolone (IV pulses) therapy. Arthritis Rheum 37: S429

    Google Scholar 

  • Pachman LM, Hayford JR, Hochberg MC et al. (1997) New-onset juvenile dermatomyositis: Comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis Rheum 40: 1526–1533

    Article  PubMed  CAS  Google Scholar 

  • Pachman LM, Hayford JR, Chung A et al. (1998) Juvenile dermatomyositis at diagnosis Clinical characteristics of 79 children. J Rheumatol 25: 1198–1204

    PubMed  CAS  Google Scholar 

  • Pachman LM, Liotta-Davis MR, Hong DK et al. (2000) TNFalpha-308A allele in juvenile dermatomyositis association with increased production of tumor necrosisfactor alpha, disease duration, and pathologic calcification. Arthr Rheum 43: 2368–2377

    Article  CAS  Google Scholar 

  • Park JH, Niermann KJ, Ryder NM, Nelson AE, Das A, Lawton AR, Hernanz-Schulman M, Olsen NJ (2000) Muscle abnormalities in juvenile dermatomyositis patients. Arthritis Rheum 43: 2359–2367

    Article  PubMed  CAS  Google Scholar 

  • Prieur AM (ed) (1999) Rhumatologie pédiatrique. Flammarion, Paris

    Google Scholar 

  • Ramanan AV, Campbell-Webster N, Ota S et al. (2005) The eff ectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids. Arthritis Rheum 52: 3570–3578

    Article  PubMed  CAS  Google Scholar 

  • Reed AM, Pachman I, Ober C (1991) Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with HLA-DQAI’0501. Hum Immunol 32: 235–240

    Article  PubMed  CAS  Google Scholar 

  • Reed AM, Pachman LM, Hayford J et al. (1998) Immunogenetic studies in families of children with juvenile dermatomyositis. J Rheumatol 25: 1000–1002

    PubMed  CAS  Google Scholar 

  • Reed AM, Picornell YJ, Harwood A et al. (2000) Chimerism in children with juvenile dermatomyositis. Lancet 356: 2156–2157

    Article  PubMed  CAS  Google Scholar 

  • Reed AM, Lopez M. (2002) Juvenile dermatomyositis: recognititon and treatment. Paediatr Drugs 4: 315–321

    PubMed  Google Scholar 

  • Reed AM, McNallan K, Wettstein P et al. (2004) Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis. J Immunol 172: 5041–5046

    PubMed  CAS  Google Scholar 

  • Reiff A, Rawlings DJ, Shaham B et al. (1997) Preliminary evidence for cyclosporine A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis. J Rheumatol 24: 2436–2443

    PubMed  CAS  Google Scholar 

  • Ruperto N, Ravelli A, Murray KJ et al. for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG) (2003) Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematodes and juvenile dermatomyositis. Rheumatology 42: 1452

    Article  PubMed  Google Scholar 

  • Stockton D, Doherty VR, Brewster DH (2001) Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 85: 41

    Article  PubMed  CAS  Google Scholar 

  • Sullivan DB, Cassidy JT, Petty RE (1977) Dermatomyositis in the pediatric patient. Arthritis Rheum 20: 327–331

    PubMed  CAS  Google Scholar 

  • Summers RM, Brune AM, Choyke PL et al. (1998) Juvenile idiopathic inflammatory myopathy: exercise-induced changes in muscle at short inversion time inversion-recovery MR imaging. Radiology 209: 191–196

    PubMed  CAS  Google Scholar 

  • Symmons DP, Sills JA, Davis SM (1995) The incidence of juvenile dermatomyositis results from a nation-wide study. Br J Rheumatol 34: 732–736

    Article  PubMed  CAS  Google Scholar 

  • Taieb A, Guichard C, Salamon R, Maleville J (1985) Prognosis in juvenile dermatopolymyositis: a cooperative terospective study of 70 cases. Pediatr Dermatol 2: 275–281

    PubMed  CAS  Google Scholar 

  • Targoff IN (2002) Laboratory testing in the diagnosis of idiopathic in-fl ammatory myopathies. Rheum Dis Clin N Am 28: 859–890

    Article  Google Scholar 

  • Tezak Z, Hoffman EP, Lutz JL et al. (2002) Gene expression profi ling in DQAI’0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol 168: 4154–4163

    PubMed  CAS  Google Scholar 

  • Uzel G, Pachman LM (2003) Cytokines in juvenile dermatomyositis pathophysiology: potential and challenge. Curr Opin Rheumatol 15: 691–697

    Article  PubMed  CAS  Google Scholar 

  • Vavrincova P, Havelka S, Cerna M et al. (1993) HLA class II alleles in juvenile dermatomyositis. J Rheumatol 37(Suppl): 17–18

    CAS  Google Scholar 

  • Webster AD, Tripp JH, Hayward AR et al. (1978) Echovirus encephalitis and myositis in primary immunoglobulin deficiency. Arch Dis Child 53: 33

    Article  PubMed  CAS  Google Scholar 

  • Yoshimasu T, Ohtani T, Sakamoto T et al. (2002) Topical FK 506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. Eur J Dermatol 12: 50–52

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kinderheilkunde I, Medizinische Hochschule Hannover, Carl-Neuberg-Str.1, 30625, Hannover

    A. Thon (Dr. med.)

  2. Klinik und Poliklinik für Kinderheilkunde, Fetscherstr. 74, 01307, Dresden

    M. Gahr (Prof. Dr. med.)

Authors
  1. A. Thon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Gahr
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Kinder- und Jugendmedizin, RWTH Aachen, Pauwelsstr. 30, 52074, Aachen

    Norbert Wagner

  2. Olgahospital, Klinikum Stuttgart, Pädiatrisches Zentrum der Landeshauptstadt Stuttgart, Bismarckstr. 8, 70176, Stuttgart

    Günther Dannecker

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Thon, A., Gahr, M. (2007). Dermatomyositis. In: Wagner, N., Dannecker, G. (eds) Pädiatrische Rheumatologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-32815-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-32815-5_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-32814-8

  • Online ISBN: 978-3-540-32815-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation